{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:49:22Z","timestamp":1787986162808,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Current soil-transmitted helminth (STH) control guidelines endorse the use of albendazole or mebendazole for school-based targeted preventive chemotherapy (PC), yet their reduced efficacy against <jats:italic>Strongyloides stercoralis<\/jats:italic> and <jats:italic>Trichuris trichiura<\/jats:italic> presents significant limitations. Emerging evidence indicates that community-wide PC [or mass drug administration (MDA)] using ivermectin, commonly used in other neglected tropical disease (NTD) control programs, may play an important role in controlling these parasites. We conducted a systematic review and meta-analysis to evaluate the effectiveness of ivermectin PC in reducing STH prevalence in endemic populations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched Pubmed, EMBASE, and Web of Science on February 14, 2023, for studies that investigated the effectiveness of ivermectin PC, either alone or in combination with other anthelmintic drugs, on STH infections, and provided a measure of STH prevalence before and after PC. We calculated pooled prevalence reductions for each STH using random-effects meta-analyses. Our protocol is available on PROSPERO (registration number CRD42023401219).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 21 were eligible for the systematic review, of which 15 were eligible for meta-analysis. All studies delivered ivermectin through MDA. The pooled prevalence reduction of <jats:italic>S. stercoralis<\/jats:italic> following MDA with ivermectin alone was 84.49% (95% <jats:italic>CI<\/jats:italic> 54.96\u201394.66) across five studies and 81.37% (95% <jats:italic>CI<\/jats:italic> 61.62\u201390.96) across seven studies with or without albendazole. The prevalence reduction of <jats:italic>T. trichiura<\/jats:italic> was 49.93% (95% <jats:italic>CI<\/jats:italic> 18.23\u201369.34) across five studies with ivermectin alone, and 89.40% (95% <jats:italic>CI<\/jats:italic> 73.66\u201395.73) across three studies with the addition of albendazole. There was high heterogeneity for all syntheses (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009&gt;\u200965%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study underscores the key role of ivermectin-based MDA in addressing limitations in current global STH guidelines in terms of limited efficacy against <jats:italic>S. stercoralis<\/jats:italic> and <jats:italic>T. trichiura<\/jats:italic>. Based on these findings, revising international STH guidelines to include ivermectin is a promising option to progress the control and eventual elimination of STHs and other NTDs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40249-024-01185-5","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T10:01:41Z","timestamp":1708250501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness of ivermectin mass drug administration in the control of soil-transmitted helminth infections in endemic populations: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7060-5943","authenticated-orcid":false,"given":"Brandon","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Vaz","family":"Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,18]]},"reference":[{"issue":"10159","key":"1185_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","journal-title":"Lancet"},{"issue":"10159","key":"1185_CR2","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","volume":"392","author":"HH Kyu","year":"2018","unstructured":"Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859\u2013922.","journal-title":"Lancet"},{"issue":"6","key":"1185_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/pathogens9060468","volume":"9","author":"D Buonfrate","year":"2020","unstructured":"Buonfrate D, Bisanzio D, Giorli G, Odermatt P, Furst T, Greenaway C, et al. The global prevalence of Strongyloides stercoralis infection. Pathogens. 2020;9(6):468.","journal-title":"Pathogens"},{"issue":"6","key":"1185_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4269\/ajtmh.18-0895","volume":"100","author":"F Tamarozzi","year":"2019","unstructured":"Tamarozzi F, Martello E, Giorli G, Fittipaldo A, Staffolani S, Montresor A, et al. Morbidity associated with chronic Strongyloides stercoralis infection: a systematic review and meta-analysis. Am J Trop Med Hyg. 2019;100(6):1305\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"1185_CR5","unstructured":"World Health Organisation (WHO). Preventive chemotherapy to control STH infection in at risk population groups. 2017."},{"issue":"1","key":"1185_CR6","first-page":"96","volume":"68","author":"NE Clarke","year":"2019","unstructured":"Clarke NE, Doi SAR, Wangdi K, Chen Y, Clements ACA, Nery SV. Efficacy of anthelminthic drugs and drug combinations against soil-transmitted helminths: a systematic review and network meta-analysis. Clin Infect Dis. 2019;68(1):96\u2013105.","journal-title":"Clin Infect Dis"},{"key":"1185_CR7","first-page":"CD007745","volume":"1","author":"C Henriquez-Camacho","year":"2016","unstructured":"Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC Jr, Terashima A, Samalvides F, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016;1:CD007745.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1185_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijpddr.2011.09.002","volume":"1","author":"J Vercruysse","year":"2011","unstructured":"Vercruysse J, Albonico M, Behnke JM, Kotze AC, Prichard RK, McCarthy JS, et al. Is anthelmintic resistance a concern for the control of human soil-transmitted helminths? Int J Parasitol Drugs Drug Resist. 2011;1(1):14\u201327.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"10","key":"1185_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.pt.2004.07.010","volume":"20","author":"AJ Wolstenholme","year":"2004","unstructured":"Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC. Drug resistance in veterinary helminths. Trends Parasitol. 2004;20(10):469\u201376.","journal-title":"Trends Parasitol"},{"issue":"5","key":"1185_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4269\/ajtmh.1996.55.477","volume":"55","author":"H Marti","year":"1996","unstructured":"Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, Ameir JS, et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg. 1996;55(5):477\u201381.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"1185_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5897\/AJB2003.000-1093","volume":"2","author":"AA Adenusi","year":"2003","unstructured":"Adenusi AA, Oke AO, Adenusi AO. Comparison of ivermectin and thiabendazole in the treatment of uncomplicated human Strongyloides stercoralis infection. Afr J Biotechnol. 2003;2(11):465\u20139.","journal-title":"Afr J Biotechnol"},{"issue":"1","key":"1185_CR12","first-page":"35","volume":"81","author":"VY Belizario","year":"2003","unstructured":"Belizario VY, Amraillo ME, de Leon WU, de los Reyes AE, Bugayong MG, Macatangay BJC. A comparison of the efficacy of single doses of ALB, IVM, and DBMZ alone or in combinations against Ascaris and Trichuris spp. Bull World Health Organ. 2003;81(1):35\u201342.","journal-title":"Bull World Health Organ"},{"issue":"8","key":"1185_CR13","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/cid\/ciy246","volume":"67","author":"D Wimmersberger","year":"2018","unstructured":"Wimmersberger D, Coulibaly JT, Schulz JD, Puchkow M, Huwyler J, N\u2019Gbesso Y, et al. Efficacy and safety of ivermectin against Trichuris trichiura in preschool-aged and school-aged children: a randomized controlled dose-finding trial. Clin Infect Dis. 2018;67(8):1247\u201355.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1185_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.pt.2014.07.005","volume":"30","author":"S Omura","year":"2014","unstructured":"Omura S, Crump A. Ivermectin: panacea for resource-poor communities? Trends Parasitol. 2014;30(9):445\u201355.","journal-title":"Trends Parasitol"},{"issue":"24","key":"1185_CR15","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","volume":"373","author":"L Romani","year":"2015","unstructured":"Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass drug administration for scabies control in a population with endemic disease. N Engl J Med. 2015;373(24):2305\u201313.","journal-title":"N Engl J Med"},{"issue":"11","key":"1185_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003849","volume":"18","author":"M Hardy","year":"2021","unstructured":"Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, Whitfeld MJ, et al. Community control strategies for scabies: a cluster randomised noninferiority trial. PLoS Med. 2021;18(11): e1003849.","journal-title":"PLoS Med"},{"issue":"8","key":"1185_CR17","first-page":"563","volume":"82","author":"J Heukelbach","year":"2004","unstructured":"Heukelbach J, Winter B, Wilcke T, Muehlen M, Albrecht S, de Oliveira FA, et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ. 2004;82(8):563\u201371.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"1185_CR18","first-page":"681","volume":"14","author":"A Knudson","year":"2012","unstructured":"Knudson A, Ariza Y, Lopez MC, Fejardo OS, Reyes P, Moncada LI, et al. Impacto de la ivermectina sobre sobre las geohelmintiasis en el foco de oncocercosis en Colombia (The effect of ivermectin on geohelminth frequency i.e. as used in the onchocerciasis control program in Colomia). Rev Salud publica. 2012;14(4):681\u201394. (in Spanish)","journal-title":"Rev Salud publica"},{"issue":"12","key":"1185_CR19","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1093\/cid\/ciaa584","volume":"71","author":"M Marks","year":"2020","unstructured":"Marks M, Gwyn S, Toloka H, Kositz C, Asugeni J, Asugeni R, et al. Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children. Clin Infect Dis. 2020;71(12):3226\u20138.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1185_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40249-019-0553-5","volume":"8","author":"YM Bah","year":"2019","unstructured":"Bah YM, Bah MS, Paye J, Conteh A, Saffa S, Tia A, et al. Soil-transmitted helminth infection in school age children in Sierra Leone after a decade of preventive chemotherapy interventions. Infect Dis Poverty. 2019;8(1):41.","journal-title":"Infect Dis Poverty"},{"issue":"10","key":"1185_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006003","volume":"11","author":"A Echazu","year":"2017","unstructured":"Echazu A, Juarez M, Vargas PA, Cajal SP, Cimino RO, Heredia V, et al. Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: a community-based pragmatic study. PLoS Negl Trop Dis. 2017;11(10): e0006003.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1185_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.trstmh.2008.07.011","volume":"103","author":"K Massa","year":"2009","unstructured":"Massa K, Magnussen P, Sheshe A, Ntakamulenga R, Ndawi B, Olsen A. The combined effect of the lymphatic filariasis elimination programme and the schistosomiasis and soil-transmitted helminthiasis control programme on soil-transmitted helminthiasis in schoolchildren in Tanzania. Trans R Soc Trop Med Hyg. 2009;103(1):25\u201330.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"11","key":"1185_CR23","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1111\/j.1365-3156.2006.01730.x","volume":"11","author":"JB Ziem","year":"2006","unstructured":"Ziem JB, Olsen A, Magnussen P, Horton J, Spannbrucker N, Yelifari L, et al. Annual mass treatment with albendazole might eliminate human oesophagostomiasis from the endemic focus in northern Ghana. Trop Med Int Health. 2006;11(11):1759\u201363.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"1185_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4269\/ajtmh.16-0857","volume":"97","author":"P Vargas","year":"2017","unstructured":"Vargas P, Krolewiecki AJ, Echaz\u00fa A, Juarez M, Cajal P, Gil JF, et al. Serologic monitoring of public health interventions against Strongyloides stercoralis. Am J Trop Med Hyg. 2017;97(1):166\u201372.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"1185_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.4269\/ajtmh.21-0768","volume":"106","author":"OA Eneanya","year":"2022","unstructured":"Eneanya OA, Gankpala L, Goss CW, Bolay FK, Weil GJ, Fischer PU. Impact of annual versus semiannual mass drug administration with ivermectin and albendazole on helminth infections in Southeastern Liberia. Am J Trop Med Hyg. 2022;106(2):700\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"1185_CR26","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol. 2021;74(9):790\u20139.","journal-title":"Rev Esp Cardiol"},{"issue":"10066","key":"1185_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0140-6736(16)32123-7","volume":"389","author":"NE Clarke","year":"2017","unstructured":"Clarke NE, Clements ACA, Doi SA, Wang D, Campbell SJ, Gray D, et al. Differential effect of mass deworming and targeted deworming for soil-transmitted helminth control in children: a systematic review and meta-analysis. Lancet. 2017;389(10066):287\u201397.","journal-title":"Lancet"},{"issue":"7","key":"1185_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011473","volume":"17","author":"G Stroffolini","year":"2023","unstructured":"Stroffolini G, Tamarozzi F, Fittipaldo A, Mazzi C, Le B, Vaz Nery S, et al. Impact of preventive chemotherapy on Strongyloides stercoralis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2023;17(7): e0011473.","journal-title":"PLoS Negl Trop Dis"},{"key":"1185_CR29","unstructured":"Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia 2023. www.covidence.org. Accessed 20 Mar 2023."},{"issue":"9","key":"1185_CR30","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1185_CR31","unstructured":"National Heart Lung and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies. 2014. http:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/in-develop\/cardiovascular-risk-reduction\/tools\/cohort. Accessed 20 Mar 2023."},{"key":"1185_CR32","unstructured":"National Heart Lung and Blood Institute. Quality assessment tool for before-after (pre\u2013post) studies with no control group. 2014. http:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/in-develop\/cardiovascular-riskreduction\/tools\/before-after. Accessed 20 Mar 2023."},{"issue":"4","key":"1185_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16(4):195\u2013203.","journal-title":"Int J Evid Based Healthc"},{"issue":"6","key":"1185_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010477","volume":"16","author":"S Ame","year":"2022","unstructured":"Ame S, Kabole F, Nanai AM, Mwinzi P, Mupfasoni D, Ali SM, et al. Impact of preventive chemotherapy on transmission of soil-transmitted helminth infections in Pemba Island, United Republic of Tanzania, 1994\u20132021. PLoS Negl Trop Dis. 2022;16(6): e0010477.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"1185_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004150","volume":"9","author":"M Anselmi","year":"2015","unstructured":"Anselmi M, Buonfrate D, Espinoza AG, Prandi R, Marquez M, Gobbo M, et al. Mass administration of ivermectin for the elimination of onchocerciasis significantly reduced and maintained low the prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador. PLoS Negl Trop Dis. 2015;9(11): e0004150.","journal-title":"PLoS Negl Trop Dis"},{"key":"1185_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2022.106437","volume":"231","author":"OA Eneanya","year":"2022","unstructured":"Eneanya OA, Gankpala L, Goss CW, Momolu AT, Nyan ES, Gray EB, et al. Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia. Acta Trop. 2022;231: 106437.","journal-title":"Acta Trop"},{"issue":"2","key":"1185_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263625","volume":"17","author":"G Gebrezgabiher","year":"2022","unstructured":"Gebrezgabiher G, Yewhalaw D, Ayana M, Hailu A, Mekonnen Z. Impact of ivermectin mass drug administration on burden of soil-transmitted helminths in onchocerciasis control and elimination programs, Yeki district, southwest Ethiopia. PLoS ONE. 2022;17(2): e0263625.","journal-title":"PLoS ONE"},{"issue":"1","key":"1185_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4269\/ajtmh.21-1207","volume":"107","author":"E Griswold","year":"2022","unstructured":"Griswold E, Eigege A, Adelamo S, Mancha B, Kenrick N, Sambo Y, et al. Impact of three to five rounds of mass drug administration on schistosomiasis and soil-transmitted helminths in school-aged children in North-Central Nigeria. Am J Trop Med Hyg. 2022;107(1):132\u201342.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"1185_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-018-2642-x","volume":"11","author":"E Hurlimann","year":"2018","unstructured":"Hurlimann E, Silue KD, Zouzou F, Ouattara M, Schmidlin T, Yapi RB, et al. Effect of an integrated intervention package of preventive chemotherapy, community-led total sanitation and health education on the prevalence of helminth and intestinal protozoa infections in Cote d\u2019Ivoire. Parasit Vectors. 2018;11(1):1\u201320.","journal-title":"Parasit Vectors"},{"issue":"6","key":"1185_CR40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4269\/ajtmh.2009.09-0377","volume":"81","author":"S Knopp","year":"2009","unstructured":"Knopp S, Mohammed KA, Rollinson D, Stothard JR, Khamis IS, Utzinger J, et al. Changing patterns of soil-transmitted helminthiases in Zanzibar in the context of national helminth control programs. Am J Trop Med Hyg. 2009;81(6):1071\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"1185_CR41","doi-asserted-by":"publisher","first-page":"e924","DOI":"10.1016\/S2214-109X(23)00134-1","volume":"11","author":"B Le","year":"2023","unstructured":"Le B, Monteiro MAAM, Amaral S, Wand H, Matthews A, Hii SF, et al. The impact of ivermectin, diethylcarbamazine, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in Timor-Leste: a beforeafter assessment. Lancet Glob Health. 2023;11:e924\u201332.","journal-title":"Lancet Glob Health"},{"key":"1185_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100942","volume":"42","author":"B Le","year":"2023","unstructured":"Le B, Clarke N, Hii SF, Byrne A, Wand H, et al. Effectiveness of one and two doses of ivermectin mass drug administration in reducing the prevalence and intensity of soil-transmitted helminth (STH) infections in Western Province, Solomon Islands: a cluster-randomised, before-after analysis. Lancet Reg Health West Pac. 2023;42: 100942.","journal-title":"Lancet Reg Health West Pac"},{"issue":"9","key":"1185_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0008642","volume":"14","author":"A Loukouri","year":"2020","unstructured":"Loukouri A, Meite A, Koudou BG, Goss CW, Lew D, Weil GJ, et al. Impact of annual and semi-annual mass drug administration for lymphatic filariasis and onchocerciasis on hookworm infection in Cote d\u2019Ivoire. PLoS Negl Trop Dis. 2020;14(9):1\u201315.","journal-title":"PLoS Negl Trop Dis"},{"key":"1185_CR44","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/0035-9203(95)90443-3","volume":"89","author":"JP Moulia-Pelat","year":"1995","unstructured":"Moulia-Pelat JP, Nguyen LN, Hasocet H, Luquiaud P, Nicolas L. Advantages of an annual single dose of ivermectin 400 mcg\/kg plus diethylcarbamazine for community treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg. 1995;89:682\u20135.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"11","key":"1185_CR45","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/j.1365-3156.2006.01729.x","volume":"11","author":"JB Ziem","year":"2006","unstructured":"Ziem JB, Magnussen P, Olsen A, Horton J, Asigri VL, Polderman AM. Impact of repeated mass treatment on human Oesophagostomum and hookworm infections in northern Ghana. Trop Med Int Health. 2006;11(11):1764\u201372.","journal-title":"Trop Med Int Health"},{"key":"1185_CR46","first-page":"467","volume-title":"Disease control priorities in developing countries","author":"PJ Hotez","year":"2005","unstructured":"Hotez PJ, Bundy AP, Beegle K, Brooker S, Drake L, de Silva N, et al. Helminth infections: soil-transmitted helminth infections and schistosomiasis. In: Disease control priorities in developing countries. New York: Oxford University Press; 2005. p. 467\u201382."},{"issue":"7","key":"1185_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002288","volume":"7","author":"F Schar","year":"2013","unstructured":"Schar F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7(7): e2288.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1185_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.parepi.2016.02.004","volume":"1","author":"HC Turner","year":"2016","unstructured":"Turner HC, Truscott JE, Bettis AA, Hollingsworth TD, Brooker SJ, Anderson RM. Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura. Parasite Epidemiol Control. 2016;1(2):177\u201387.","journal-title":"Parasite Epidemiol Control"},{"key":"1185_CR49","volume-title":"Water and sanitation for the 21st century: health and microbiological aspects of excreta and wastewater management (global water pathogen project)","author":"S Asaolu","year":"2018","unstructured":"Asaolu S, Ofoezie IE. Ascaris spp. In: Rose J, Jim\u00e9nez-Cisneros B, editors. Water and sanitation for the 21st century: health and microbiological aspects of excreta and wastewater management (global water pathogen project). East Lansing: Michigan State University, UNESCO; 2018."},{"key":"1185_CR50","volume-title":"Water and sanitation for the 21st century: health and microbiological aspects of excreta and wastewater management (global water pathogen project)","author":"R Izurieta","year":"2018","unstructured":"Izurieta R, Reina-Ortiz M, Ochoa-Capello T. Trichuris trichiura. In: Rose J, Jim\u00e9nez-Cisneros B, editors. Water and sanitation for the 21st century: health and microbiological aspects of excreta and wastewater management (global water pathogen project). East Lansing: Michigan State University, UNESCO; 2018."},{"issue":"5","key":"1185_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001621","volume":"6","author":"TW Jia","year":"2012","unstructured":"Jia TW, Melville S, Utzinger J, King CH, Zhou XN. Soil-transmitted helminth reinfection after drug treatment: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(5): e1621.","journal-title":"PLoS Negl Trop Dis"},{"key":"1185_CR52","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s13071-015-1151-4","volume":"8","author":"LE Coffeng","year":"2015","unstructured":"Coffeng LE, Bakker R, Montresor A, de Vlas SJ. Feasibility of controlling hookworm infection through preventive chemotherapy: a simulation study using the individual-based WORMSIM modelling framework. Parasit Vectors. 2015;8:541.","journal-title":"Parasit Vectors"},{"issue":"2","key":"1185_CR53","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/trstmh\/traa169","volume":"115","author":"XX Huang","year":"2021","unstructured":"Huang XX, Toure H, Biswas G. Resource tracking for neglected tropical disease programmes: the first step for developing a sustainable financing strategy. Trans R Soc Trop Med Hyg. 2021;115(2):179\u201381.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1185_CR54","unstructured":"World Health Organization (WHO). Schistosomiasis and soil-transmitted helminthiases: numbers of people treated in 2017. World Health Organization; 2018."},{"key":"1185_CR55","unstructured":"World Health Organisation (WHO). 2030 targets for soil-transmitted helminthiases control programmes: WHO; 2019."},{"key":"1185_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198545996.001.0001","volume-title":"Infectious diseases of humans: dynamics and control","author":"R Anderson","year":"1991","unstructured":"Anderson R, May RM. Infectious diseases of humans: dynamics and control. New York: Oxford Science Publications; 1991."}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-024-01185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-024-01185-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-024-01185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T11:02:04Z","timestamp":1708254124000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-024-01185-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1186\/s40249-024-01185-5","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,18]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}